---
title: "維亞生物回購維亞上海義務獲投資人暫持擱置"
description: "維亞生物宣佈，維亞上海的投資人同意在 2026 年 12 月 31 日至 2028 年 12 月 31 日期間暫時擱置回購其股權的權利。這些投資人包括 HLC SPV、青島弘熠、Daxue Investments、True Light P 及 Raed Capital Holdings 2。根據股東協議，投資人有權在維亞上海未能在 2026 年 12 月 31 日之前完成合格首次公開發行或實現合格"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/271517952.md"
published_at: "2026-01-05T13:07:51.000Z"
---

# 維亞生物回購維亞上海義務獲投資人暫持擱置

> 維亞生物宣佈，維亞上海的投資人同意在 2026 年 12 月 31 日至 2028 年 12 月 31 日期間暫時擱置回購其股權的權利。這些投資人包括 HLC SPV、青島弘熠、Daxue Investments、True Light P 及 Raed Capital Holdings 2。根據股東協議，投資人有權在維亞上海未能在 2026 年 12 月 31 日之前完成合格首次公開發行或實現合格併購交易時回購其持有的股權。

維亞生物 (01873.HK) 公佈，公司收到維亞上海投資人 (包括 HLC SPV、青島弘熠、Daxue Investments 及 True Light P 及 Raed Capital Holdings 2) 函件，不可撤回地同意在 2026 年 12 月 31 日至 2028 年 12 月 31 日的任何時間內，暫時擱置要求公司根據回購義務回購彼等於維亞上海股權的權利。

根據股東協議，維亞上海投資人有權在維亞上海未能於 2026 年 12 月 31 日或之前完成合格首次公開發行或實現合格併購交易的情況人，回購其持有的股權。

### Related Stocks

- [01873.HK - 維亞生物](https://longbridge.com/zh-HK/quote/01873.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| VIVA Biotech Investors Suspend Repurchase Rights for Shanghai VIVA Equity | VIVA Biotech Holdings announced that investors, including HLC SPV and others, have temporarily suspended their right to  | [Link](https://longbridge.com/zh-HK/news/271493678.md) |
| Viva Biotech Expands Pharmacology Platform to Support Diverse Drug Modalities | Viva Biotech Holdings has expanded its pharmacology platform, enhancing DMPK, pharmacology, and efficacy services. The c | [Link](https://longbridge.com/zh-HK/news/270955785.md) |
| Kangqiao Service Says On Feb 12 Unit Received Civil Judgment | Kangqiao Service Group Ltd :ON FEB 12 UNIT RECEIVED CIVIL JUDGMENT FROM COURT IN RELATION TO APPEALCONSIDERS SECOND CIVI | [Link](https://longbridge.com/zh-HK/news/275924000.md) |
| HSBC Bank Makes Early Repurchase of $14 Million USD Notes | HSBC Bank Makes Early Repurchase of $14 Million USD Notes | [Link](https://longbridge.com/zh-HK/news/275792057.md) |
| AB InBev buys back 404,496 units for EUR 26,306,936 | Anheuser-Busch InBev SA has repurchased 404,496 shares for EUR 26,306,936, averaging EUR 65.04 per share, as part of its | [Link](https://longbridge.com/zh-HK/news/276079337.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。